Global Multiplex Testing Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 2.00 Billion |
 Market Size (Forecast Year) |
USD 3.84 Billion |
 CAGR |
% |
| Major Markets Players |
>全球多重测试市场，按产品（试剂、消耗品、其他）、技术（xMAP（多分析物分析）、RT-PCR（实时聚合酶链反应）、ELISA（酶联免疫吸附试验）、其他）、应用（甲型流感、乙型流感、副流感病毒、腺病毒、呼吸道合胞病毒 (RSV)、冠状病毒、人类偏肺病毒 (hMPV)、鼻病毒和肠道病毒）、最终用户（医院、临床实验室、制药和生物技术公司、研究机构、其他）划分——行业趋势和预测到 2029 年。
多重测试市场分析和规模
多重检测检查导致多种不同呼吸道感染（如 COVID-19、RSV、流感）的病毒产生的遗传物质。这可确定个体是否感染了其中任何一种疾病。多重 PCR 可用于诊断目的，例如处理大样本或发现许多相似的物种，也可用于同时比较多种遗传产物的表达。
Data Bridge Market Research 分析，多重测试市场在 2021 年为 20 亿美元，到 2029 年将飙升至 38.4 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 8.50%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
多重测试市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制为 2014 - 2019） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
产品（试剂、耗材、其他）、技术（xMAP（多分析物分析）、RT-PCR（实时聚合酶链反应）、ELISA（酶联免疫吸附试验）、其他）、应用（甲型流感、乙型流感、副流感病毒、腺病毒、呼吸道合胞病毒 (RSV)、冠状病毒、人类偏肺病毒 (hMPV)、鼻病毒和肠道病毒）、最终用户（医院、临床实验室、制药和生物技术公司、研究机构、其他） |
|
覆盖国家 |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
|
Market Players Covered |
BD (U.S.), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Illumina, Inc. (U.S.), QIAGEN (Germany), Abcam plc. (U.K.), Agilent Technologies, Inc. (U.S.), MESO SCALE DIAGNOSTICS, LLC. (U.S.), Randox Laboratories Ltd. (U.K.), Quanterix (U.S.), Bio-Techne. (U.S.), Olink (U.S.), Seegene Inc. (South Korea) |
|
Market Opportunities |
|
Market Definition
The genetic material from viruses that cause a variety of respiratory diseases is checked with this test (such as COVID-19, influenza, and RSV). This establishes whether a person is currently infected with one of these diseases. The time and expenses associated with conducting individual tests are reduced by multiplex testing.
Global Multiplex Testing Market Dynamics
Drivers
- Surging volume of patients suffering from respiratory disorders
The most prevalent acute and chronic diseases worldwide are respiratory illnesses. Regardless of the degree of progress in a society, they are prevalent throughout all age groups and population segments. Respiratory viral infections play an increasing role in community-acquired pneumonia (CAP) in adult patients, as more rapid and sensitive diagnostic methods based on PCR techniques are being developed. This will boost market growth.
- Rise in the personalized medicine
Personalized medicine, which has gained popularity recently, endeavours to give each patient a treatment plan that is specifically designed for them based on the molecular cause of their illness. Companion diagnostics are quickly growing in number and use in disease areas and are becoming an essential component of customised treatment. According to the current product pipeline, companion diagnostics are expected to increase quickly in the near future. The growth of the global market for multiplex testing is anticipated to be significantly impacted by this expansion of companion diagnostics.
Opportunities
- Growing application of multiplex testing in emerging economies
The multiplex assay has emerged as a result of the validation of numerous disease indicators in both molecular and protein diagnostics. The immunoassay was initially used to test simple low-throughput multiplex assays. These were followed by high-throughput array-based immunoassays and low-level multiplexing.
Restraints/Challenges
On the other hand, the high cost of devices along with stringent regulations and standards will obstruct the market's growth rate. The lack of skilled professionals in developing economies will challenge the multiplex testing market.
This multiplex testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the multiplex testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Multiplex Testing Market
The application of multiplex diagnostic for the diagnosis of COVID-19 and associated disorders has favourably impacted the growth of the studied market. The development of cutting-edge diagnostic tools for the detection of SARS-CoV-2 has seen a rise in research and development. Major market participants boosted their investments in creating devices or panels for multiplexed viral detection while concentrating more on innovations. As a result of the above mentioned causes, even though COVID-19 caused a lack of crucial diagnostic tests during the early stages of the pandemic, multiplex assays were crucial in delivering speedy results for COVID-19 diagnosis.
Recent Development
- In March 2020, The BIOFIRE COVID-19 test, which identifies COVID-19, the common cold, influenza, pneumonia, bronchiolitis, and even whooping cough, as well as SARS-CoV-2 and 21 other common respiratory viruses and bacteria, gained Emergency Use Authorization from bioMérieux.
- In May 2022, QuantuMDx Group Limited introduced the Q-POC SARS-CoV-2, Flu A/B & RSV Assay, a new respiratory panel test. Customers may quickly test at the point of care in a variety of healthcare settings because to its multiplex capabilities.
Global Multiplex Testing Market Scope
The multiplex testing market is segmented on the basis of product, technology, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Reagents
- Consumables
- Others
Technology
- xMAP (Multi-Analyte Profiling)
- RT-PCR (Real Time Polymerase Chain Reaction)
- ELISA (Enzyme-Linked Immunosorbent Assay)
- Others
Application
- Influenza A
- Influenza B
- Parainfluenza Viruses
- Adenovirus
- Respiratory Syncytial Virus (RSV)
- Coronaviruses
- Human Metapneumovirus (hMPV)
- Group Rhino- and Enteroviruses
End User
- Hospitals
- 临床实验室
- 制药和生物技术公司
- 研究机构
- 其他的
多重测试市场区域分析/见解
对多重测试市场进行了分析，并按国家、产品类型、技术、应用和最终用户提供了市场规模见解和趋势。
多重测试市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于医疗保健基础设施的完善和技术的先进以及医疗保健支出的不断增长，北美在多重检测市场占据主导地位。
由于传染病发病率的增加和可支配收入的提高，预计亚太地区将在 2022 年至 2029 年的预测期内以最高的增长率增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和多重测试市场份额分析
多重检测市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对多重检测市场的关注有关。
多重测试市场的一些主要参与者包括：
- BD（美国）
- 生物梅里埃公司（法国）
- Bio-Rad Laboratories, Inc.（美国）
- 赛默飞世尔科技公司（美国）
- 默克集团（德国）
- Illumina 公司（美国）
- QIAGEN（德国）
- Abcam plc.（英国）
- 安捷伦科技公司（美国）
- MESO SCALE DIAGNOSTICS, LLC.（美国）
- Randox Laboratories Ltd.（英国）
- Quanterix (美国)
- Bio-Techne.（美国）
- Olink（美国）
- Seegene Inc.（韩国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
